Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...
  • Congestive Heart Failure

    Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania

    Series series Medicine (R0)
    About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues ... Read more

    $215.09 USD

  • Silent Myocardial Ischemia

    Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania

    Edited by J. Morganroth, E. Neil Moore ...
    Series Book 88 - Developments in Cardiovascular Medicine
    Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina sufferers in the United states have frequent episodes of silent myocardial ischemia. Although it is not ... Read more

    $143.09 USD

  • The Evaluation of New Antiarrhythmic Drugs

    Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, held at Philadelphia, Pennsylvania, October 8–9, 1980

    Series series Medicine (R0)
    Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same ... Read more

    $49.49 USD

  • Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment

    Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982

    Edited by E. Neil Moore, J. Morganroth ...
    Series series Medicine (R0)
    In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three ... Read more

    $143.09 USD

  • Cardiac Arrhythmias: New Therapeutic Drugs and Devices

    Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984

    Edited by J. Morganroth, E. Neil Moore ...
    Series series Medicine (R0)
    In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become ... Read more

    $143.09 USD

  • Interventions in the Acute Phase of Myocardial Infarction

    Edited by J. Morganroth, E. Neil Moore ...
    Series series Medicine (R0)
    In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is about a 20% chance of a North American male developing myocardial in farction before the age of 65. The ... Read more

    $89.09 USD

  • Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

    Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

    Edited by J. Morganroth, E. Neil Moore ...
    Series Book 100 - Developments in Cardiovascular Medicine
    The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: ... Read more

    $188.09 USD

  • Ending Ageism, or How Not to Shoot Old People

    Series series Global Perspectives on Aging
    Winner of the MLA Prize for Independent Scholars and the APA's Florence L. Denmark Award for Contributions to Women and AgingWhen the term “ageism” was coined in 1969, many problems of exclusion seemed resolved by government programs like Social Security and Medicare. As people live longer lives, today’s great demotions of older people cut deeper into their self-worth and human relations, beyond ... Read more

    $20.89 USD

  • Audiobook

    Lessons From The Microphone

    Tuning Into the Enduring Wisdom of Visionary Leaders

    Narrated by Ashley Baillio ...

    Unabridged

    4 hours 53 min

    Lessons from the Microphone: Tuning Into the Enduring Wisdom of Visionary Leaders offers an unparalleled voyageinto the minds of our generation's transformative figures. Through the lens of Broadcaster Scott Morganroth, readers gainan intimate look into the candid conversations he's shared with these industry trailblazers.Understanding the landscape becomes essential in an age where Old School ... Read more

    $6.29 USD or Free with Kobo Plus

  • The Long Year

    A 2020 Reader

    Series series Public Books Series
    Some years—1789, 1929, 1989—change the world suddenly. Or do they? In 2020, a pandemic converged with an economic collapse, inequalities exploded, and institutions weakened. Yet these crises sprang not from new risks but from known dangers. The world—like many patients—met 2020 with a host of preexisting conditions, which together tilted the odds toward disaster. Perhaps 2020 wasn’t the year the ... Read more

    $20.89 USD

  • The Big Move

    Life Between the Turning Points

    "A fascinating attempt to marry personal experience with academic analysis to help us all reconceive of one option for later-life living." — The Huffington PostWhen her husband's ill health forces them to move into an assisted living facility, Anne M. Wyatt-Brown suddenly finds herself surrounded by elderly residents. In this lively and provocative collection, other distinguished gerontologists ... Read more

    $12.99 USD or Free with Kobo Plus

  • Literature and Ageing

    The central focus of this book is the experience of growing old as represented in literature from the mid-nineteenth century to the present day: an experience shaped by changes in longevity, a new science of senescence, the availability of state pensions, and other phenomena of recent history. The collection considers the increasing prominence of stories of ageing, challenging the idea that old ... Read more

    $17.99 USD